Corcept Therapeutics (CORT) Cash from Investing Activities (2012 - 2026)
Corcept Therapeutics recorded quarterly Cash from Investing Activities of $4.5 million in Q1 2026, up 138.35% quarter-over-quarter from -$11.8 million in Q4 2025, and up 243.24% year-over-year from $1.3 million in Q1 2025.
Corcept Therapeutics' Cash from Investing Activities history runs 15 years deep, the most recent figure standing at $4.5 million for Q1 2026.
- In Q1 2026, Cash from Investing Activities rose 243.24% year-over-year to $4.5 million; the TTM figure through Mar 2026 stood at $77.5 million (up 145.1% YoY), while the FY2025 annual figure was $69.8 million, up 139.28% from the prior year.
- Cash from Investing Activities came in at $4.5 million for Q1 2026 at Corcept Therapeutics, up from -$11.8 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $207.5 million in Q1 2023 to a low of -$109.6 million in Q3 2023.
- A 5-year average of -$7.5 million and a median of -$11.8 million in 2025 frame the typical range for Cash from Investing Activities.
- On a YoY basis, Cash from Investing Activities climbed as much as 510.87% in 2023 and fell as far as 2187.47% in 2023.
- Corcept Therapeutics' Cash from Investing Activities stood at -$17.2 million in 2022, then soared by 199.17% to $17.1 million in 2023, then sank by 476.42% to -$64.4 million in 2024, then surged by 81.6% to -$11.8 million in 2025, then jumped by 138.35% to $4.5 million in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered $4.5 million, -$11.8 million, and $14.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -2.89 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 638.50 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -431.90 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -428.90 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -25.54 Mn |
| 10 | Corcept Therapeutics | 7.26 Bn | 6.92 Bn | 162.02 Mn | 4.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.54 Mn |
| Mar 31, 2026 | 4.54 Mn |
| Dec 31, 2025 | -11.84 Mn |
| Dec 31, 2025 | -11.84 Mn |
| Sep 30, 2025 | 14.65 Mn |
| Sep 30, 2025 | 14.65 Mn |
| Jun 30, 2025 | 70.13 Mn |
| Jun 30, 2025 | 70.13 Mn |
| Mar 31, 2025 | -3.17 Mn |
| Mar 31, 2025 | -3.17 Mn |
| Dec 31, 2024 | -64.36 Mn |
| Dec 31, 2024 | -64.36 Mn |
| Sep 30, 2024 | -44.04 Mn |
| Sep 30, 2024 | -44.04 Mn |
| Jun 30, 2024 | -60.19 Mn |
| Jun 30, 2024 | -60.19 Mn |
| Mar 31, 2024 | -9.01 Mn |
| Mar 31, 2024 | -9.01 Mn |
| Dec 31, 2023 | 17.10 Mn |
| Dec 31, 2023 | 17.10 Mn |
| Sep 30, 2023 | -109.57 Mn |
| Sep 30, 2023 | -109.57 Mn |
| Jun 30, 2023 | -24.10 Mn |
| Jun 30, 2023 | -24.10 Mn |
| Mar 31, 2023 | 207.48 Mn |
| Mar 31, 2023 | 207.48 Mn |
| Dec 31, 2022 | -17.24 Mn |
| Dec 31, 2022 | -17.24 Mn |
| Sep 30, 2022 | -4.79 Mn |
| Sep 30, 2022 | -4.79 Mn |
| Jun 30, 2022 | -41.80 Mn |
| Jun 30, 2022 | -41.80 Mn |
| Mar 31, 2022 | -50.50 Mn |
| Mar 31, 2022 | -50.50 Mn |
| Dec 31, 2021 | 140.47 Mn |
| Dec 31, 2021 | 140.47 Mn |
| Sep 30, 2021 | -25.80 Mn |
| Sep 30, 2021 | -25.80 Mn |
| Jun 30, 2021 | 24.74 Mn |
| Jun 30, 2021 | 24.74 Mn |
| Mar 31, 2021 | -3.28 Mn |
| Mar 31, 2021 | -3.28 Mn |
| Dec 31, 2020 | 11.22 Mn |
| Dec 31, 2020 | 11.22 Mn |
| Sep 30, 2020 | -64.27 Mn |
| Sep 30, 2020 | -64.27 Mn |
| Jun 30, 2020 | -85.94 Mn |
| Jun 30, 2020 | -85.94 Mn |
| Mar 31, 2020 | 19.73 Mn |
| Mar 31, 2020 | 19.73 Mn |
| Dec 31, 2019 | -61.99 Mn |
| Dec 31, 2019 | -61.99 Mn |
| Sep 30, 2019 | -54.32 Mn |
| Sep 30, 2019 | -54.32 Mn |
| Jun 30, 2019 | -1.16 Mn |
| Jun 30, 2019 | -1.16 Mn |
| Mar 31, 2019 | -367,000.00 |
| Mar 31, 2019 | -367,000.00 |
| Dec 31, 2018 | -1.76 Mn |
| Dec 31, 2018 | -1.76 Mn |
| Sep 30, 2018 | -33.51 Mn |
| Sep 30, 2018 | -33.51 Mn |
| Jun 30, 2018 | -21.21 Mn |
| Jun 30, 2018 | -21.21 Mn |
| Mar 31, 2018 | -34.29 Mn |
| Mar 31, 2018 | -34.29 Mn |
| Dec 31, 2017 | -27.45 Mn |
| Dec 31, 2017 | -27.45 Mn |
| Sep 30, 2017 | -11.65 Mn |
| Sep 30, 2017 | -11.65 Mn |
| Jun 30, 2017 | -14.95 Mn |
| Jun 30, 2017 | -14.95 Mn |
| Mar 31, 2017 | -19.41 Mn |
| Mar 31, 2017 | -19.41 Mn |
| Dec 31, 2016 | -75,000.00 |
| Dec 31, 2016 | -75,000.00 |
| Sep 30, 2016 | -90,000.00 |
| Sep 30, 2016 | -90,000.00 |
| Jun 30, 2016 | -7,000.00 |
| Jun 30, 2016 | -7,000.00 |
| Mar 31, 2016 | -22,000.00 |
| Mar 31, 2016 | -22,000.00 |
| Dec 31, 2015 | 17,000.00 |
| Dec 31, 2015 | 17,000.00 |
| Mar 31, 2015 | -34,000.00 |
| Mar 31, 2015 | -34,000.00 |
| Sep 30, 2014 | -16,000.00 |
| Sep 30, 2014 | -16,000.00 |
| Jun 30, 2014 | -48,000.00 |
| Jun 30, 2014 | -48,000.00 |
| Mar 31, 2014 | -110,000.00 |
| Mar 31, 2014 | -110,000.00 |
| Dec 31, 2013 | -40,000.00 |
| Dec 31, 2013 | -40,000.00 |
| Sep 30, 2013 | -65,000.00 |
| Sep 30, 2013 | -65,000.00 |
| Jun 30, 2013 | -4,000.00 |
| Jun 30, 2013 | -4,000.00 |
| Mar 31, 2013 | -18,000.00 |
| Mar 31, 2013 | -18,000.00 |
| Dec 31, 2012 | -58,000.00 |
| Dec 31, 2012 | -58,000.00 |
| Sep 30, 2012 | -52,000.00 |
| Sep 30, 2012 | -52,000.00 |
| Jun 30, 2012 | -34,000.00 |
| Jun 30, 2012 | -34,000.00 |
| Mar 31, 2012 | -7,000.00 |
| Mar 31, 2012 | -7,000.00 |